Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation
Abstract
Maraviroc (MVC) is a drug approved for use as part of HAART in treatment-experienced HIV-1 patients with CCR5-tropic virus. Despite the current concerns on the alterations in adipose tissue that frequently appear in HIV-infected patients under HAART, there is no information available on the effects of MVC on adipose tissue. Here we studied the effects of MVC during and after the differentiation of human adipocytes in culture, and compared the...
Paper Details
Title
Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation
Published Date
Mar 1, 2013
Journal
Volume
61
Issue
3
Pages
808 - 815
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History